Objective: Our aim was to assess the safety and efficacy of transpyloric tube feeding as a therapeutic option to reduce apnea and bradycardia in hospitalized very low birthweight (VLBW) infants with clinical signs suggestive of gastroesophageal reflux (GER).
Introduction
The clinical diagnosis of gastroesophageal reflux (GER) is common among preterm infants having apnea and bradycardia. Earlier studies of preterm infants suggested an association between GER and apnea; [1] [2] [3] however, more recent studies using combined pH and multichannel intraluminal impedance monitoring have challenged these findings. [4] [5] [6] [7] [8] Although a temporal relationship between GER and apnea of prematurity remains an ongoing debate, therapeutic interventions including anti-reflux medications and transpyloric tube (TPT) feeding are frequently used in this population with little evidence to support their use. [9] [10] [11] TPT feeding in preterm infants bypasses the stomach and, theoretically, reduces the potential for GER that occurs secondary to lower esophageal sphincter relaxation or delayed gastric emptying. A recent Cochrane review of nine randomized controlled trials of transpyloric versus gastric feeding in preterm infants concluded that there was no evidence for improved 'feeding tolerance' or growth with TPT feeds, but found an increased risk for 'gastrointestinal disturbance' requiring cessation of feeds. 12 No increased risk for necrotizing enterocolitis (NEC), spontaneous intestinal perforation, aspiration pneumonia, or mortality was reported when allocation bias was controlled. The trials included in the review evaluated TPT feeding as an initial feeding strategy versus gastric feeding for improved growth and feeding tolerance, whereas TPT feeding has not been evaluated as a treatment method for reducing GER episodes or episodes of autonomic instability, such as apnea and bradycardia, occurring in very preterm infants suspected of having GER.
Our objectives in this study were to assess (1) whether or not TPT feedings reduced cardiorespiratory episodes, and (2) the safety of this intervention in a population of very low birthweight (VLBW) infants with suspected GER.
Methods
This was a review of all VLBW (BW<1500 g) infants who were hospitalized at Duke University Medical Center from 1 January 2001 to 31 December 2004 with signs of GER with gastric feedings, and who then received TPT feedings. We identified patients by reviewing the discharge summaries of all VLBW infants having a hospital charge for a TPT from unit stock or for placement of a TPT in the Department of Radiology. The determination of each infant's GER diagnosis and need for TPT feeding was by the neonatal attending on service. Our unit protocol for treating GER reserves the use of TPT feeding for those infants whose episodes of suspected GER are excessive or severe and who have failed trials of other GER treatments, including: positional changes, changes to the feeding schedule, elemental formulae, and anti-reflux medications, including antacids and metoclopramide.
Transpyloric enteral feeding tubes were placed fluoroscopically by a pediatric radiologist or advanced by the bedside nurse and confirmed by abdominal radiograph. An 8-French, polyurethane, non-weighted feeding tube was inserted by nasoduodenal route, regardless of the placement method. Feedings were then given continuously by pump.
Episodes of apnea >10 s and bradycardia <100 beats per min were recorded by the bedside nurse as alerted by bedside impedance monitoring. We compared cardiorespiratory episodes before and after the initiation of TPT feedings at 1-day and combined 3-day intervals. The Wilcoxon signed-rank test was used to compare differences between daily cardiorespiratory episodes before and after TPT feedings were initiated.
Safety was monitored by noting episodes of death, sepsis, NEC or spontaneous intestinal perforation. Sepsis was determined by positive blood culture, excluding untreated coagulase negative staphylococcus. NEC was defined by radiographic (Bell's Stage IIA or greater) or surgical evidence. Descriptive statistics were used to summarize safety results, whereas Fisher's exact and Kruskal-Wallis tests were used to compare the factors of those that developed NEC and those that did not.
Infant sociodemographic, perinatal and neonatal course history were also documented. This study was approved by Duke University's Institutional Review Board.
Results
A total of 72 VLBW infants with a median birth weight of 870 g (range 365 to 1435 g) and gestational age of 26 weeks (23 to 31 weeks) were included ( Table 1 ). The median weight at initiation of transpyloric feedings was 1297 g (820 to 3145 g) and age was 59 days (10 to 177 days). Infants received feeds by this route for a median duration of 18 days (1 to 86 days).
Efficacy assessments
A reduction was observed in apnea episodes from 4.0 for the combined 3 days before treatment to 2.5 for the combined 3 days after initiation of TPT feedings (P ¼ 0.02) ( Figure 1 ). On the immediate day before and after initiating TPT feeds, the number of Transpyloric feeding reduces apnea and bradycardia in preterms WF Malcolm et al apnea episodes decreased from 2.4 to 2.0 (P ¼ 0.10). We observed a decrease in total bradycardia episodes from 7.2 to 4.5 (P<0.001) in the 3-day intervals before and after TPT placement, and a reduction from 4.6 to 3.2 (P<0.01) on the immediate day before and after the initiation of TPT feeds.
Safety assessments
Five (6.9%) of the 72 infants developed NEC while receiving TPT feedings, similar in number when compared with those developing NEC before initiating (9.7%) or after discontinuing (8.3%) TPT feeds ( Table 2 ). The infants who developed NEC during TPT feedings were similar to those who did not develop NEC with respect to birth weight, gestational age, gender, race, age and weight at the time of initiating TPT feeding ( Table 3 ). None of the infants receiving human milk during TPT feeding developed NEC (P ¼ 0.07) and 36% of those receiving hydrolysate-based formula developed NEC (P<0.01). Seven (9.7%) of the infants died before hospital discharge. Two infants died after developing NEC while receiving TPT feeds. Five others died from complications of extreme prematurity and their death was not temporally related to TPT feeds, including one each from complications of bronchopulmonary dysplasia, severe hydrocephalus, pulmonary hypertension, pulmonary hypoplasia, and one who died from congenital heart disease. No infant had an episode of sepsis or spontaneous intestinal perforation while receiving TPT feedings.
Discussion
A definite causal relationship between GER and episodes of apnea and bradycardia remains elusive. It is likely that clinicians overdiagnose GER, attempting to explain a reason for the cardiorespiratory episodes related to immaturity of multiple physiologic functions. Although it may be difficult to determine whether or not the cardiorespiratory instability elicited the reflux response, or the reflux of milk into the hypopharynx elicited the cardiorespiratory response, clinicians often seek therapeutic options to reduce these episodes in VLBW infants. Agreeing on the best therapeutic approach to this situation, however, has been challenging and has included alterations in optimal nutrition, use of medications with known risks, and even surgery. 13 We have included the use of TPT feeding in our approach to the infant with apparent GER and recalcitrant cardiorespiratory instability.
Using the preterm infant as his own control, we found that TPT feeding reduces both apnea and bradycardia when compared with gastric feeds. It is possible that TPT feeds reduce GER episodes by allowing the milk to bypass the stomach, thereby reducing obstructive apnea associated with milk refluxed to the proximal esophagus and hypopharynx. However, it may be that TPT feeding simply decreases gastric distention associated with poorer respiratory function in bolus-fed preterm infants. 14 The impact of TPT feeding on acid and non-acid reflux episodes and associated cardiorespiratory events in preterm infants has not been evaluated by randomized controlled trial.
One of the problems of diagnosing and treating GER in preterm infants is the lack of standard practice guidelines. The North American Society for Pediatric Gastroenterology and Nutrition Clinical Practice Guidelines for the evaluation and management of infants and children with suspected GER are not intended to be used for the management of neonates <72 h old, premature infants or infants with neurological impairments. 15 Thus, neonatologists often start empirical treatment, though behavioral symptoms and cardiorespiratory signs are often poorly predictive of GER and effective medical treatments have not been determined. 16, 17 Misra et al. also described a reduction in GER-associated apnea with TPT feeding in a small number of preterm infants and suggested using bedside-placed TPTs as a diagnostic tool for GER in this population. 18 Regardless of the mechanism for reducing apnea, we feel that this feeding method should be considered as a temporary treatment option in preterm infants with 'excessive or severe' apnea or bradycardia events. Its effectiveness in improving these events should be evident within 24 to 72 h.
A current systematic review comparing gastric versus TPT feeds in preterm infants has cautioned of a possible increased risk of mortality and feeding intolerance with TPT feeds. The increased mortality, however, disappeared when allocation bias was controlled. There were no differences in NEC, spontaneous perforation, sepsis or aspiration pneumonia. 12 Although 7% of the babies in our study population developed NEC while receiving TPT feeds, this was similar to the number who developed NEC before or after receiving TPT feedings. It is noted that, 40% of the infants in our study received maternal breastmilk (non-donor) during TPT feedings and none of those infants developed NEC, whereas 15% of the infants received hydrolysate-based formula during TPT feeds and over one-third of them developed NEC.
This study is limited by the retrospective nature of the data collection and the unblinded evaluation of the bedside nurse to the intervention of TPT feedings. The number of recorded events in this study is quite likely lower than the true incidence, as bedside impedance monitoring and clinical nursing notation usually underestimates actual events. Lastly, although maturation may account for a decrease in cardiorespiratory events, it is unlikely that a maturational improvement would be significant when comparing both 1-and 3-day intervals in a preterm infant who is 2 months old. A randomized controlled trial would be necessary to properly the determine efficacy of this intervention.
Conclusion
Transpyloric tube feedings are effective in reducing apnea and bradycardia in preterm infants with suspected GER. This method of feeding appears to be safe enough to warrant a clinical trial in a select population of preterm infants having excessive or severe apnea or bradycardia episodes suspected to be related to GER, particularly if the source of nutrition is human milk. Pivotal prospective studies of treatment methods for GER in preterm babies with clear inclusion criteria and outcome measures are needed to make more uniform evidence-based clinical practice recommendations.
